GlassScriptPhysician profile
Haitham Masri
NPI 1629247481
$3,077.39
in general payments reported to CMS, 2019-2025
22 companies · $32.36 in 2025
The $32.36 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,951 · 2020: $233 · 2021: $502 · 2022: $52.95 · 2023: $59.05 · 2024: $248 · 2025: $32.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,030.29 | 2019-2020 | |
| Merz North America, INC. | $440.65 | 2019-2021 | |
| Optinose US, INC. | $246.19 | 2019-2022 | |
| Inari Medical, INC. | $188.96 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sunovion Pharmaceuticals INC. | $172.68 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $167.33 | 2019-2021 | |
| Abbvie INC. | $150.15 | 2023-2025 | |
| Pfizer INC. | $149.49 | 2019 | |
| Allergan, INC. | $98.26 | 2019-2022 | |
| Mylan Specialty L.P. | $92.58 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $72.78 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $35.84 | 2020-2021 | |
| Nalpropion Pharmaceuticals LLC | $33.03 | 2019 | |
| Stryker Corporation | $32.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.88 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.79 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $21.25 | 2019 | |
| Galderma Laboratories, L.P. | $21.22 | 2021 | |
| Medtronic, INC. | $18.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.53 | 2019 | |
| Apyx Medical Corporation | $17.71 | 2019 | |
| Merck Sharp & Dohme LLC | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haitham Masri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.